Background Pharmacotherapy combinations have been shown to improve survival and reduce hospitalisations in adults with ...

The AACE update to its 2026 algorithm for the management of type 2 diabetes includes a new section on diabetes classification ...

If Kerendia secures a label expansion, it would become available to more than half of the overall CKD patient population who ...

The Phase III study FIND-CKD ( NCT05047263) — investigating the efficacy and safety of KERENDIA ® (finerenone) versus placebo when added to standard of care in adult patients with non-diabetic chronic ...

Vertex Pharmaceuticals (NasdaqGS:VRTX) reported positive Phase 3 RAINIER data for povetacicept in IgA nephropathy, meeting ...

Bayer announces finerenone meets primary endpoint in pivotal phase III FIND-CKD study in patients with non-diabetic chronic kidney disease: Berlin Tuesday, March 17, 2026, 15:00 H ...

Chronic kidney disease affects approximately 850 million people globally, with hyperkalemia representing a disproportionately high burden in this population¹. While hyperkalemia occurs in only 2-3% of ...

Rookies can be an enigma in fantasy baseball. These young players dominate the minor leagues and occasionally give fantasy ...

The Pittsburgh Pirates have rewarded Paul Skenes' dominance with a salary over $1 million, marking just the third time in MLB ...

Hypertension is both a symptom and complication of kidney disease. With C3G and IC-MPGN, blood pressure management is a foundational ‘shield’ that protects kidney function regardless of other ...

High blood pressure and kidney disease are two serious health problems that often occur together. When they appear at the ...